Based on 5 analysts giving stock ratings to Clover Health Investments Corp in the past month.
In the current month, CLOV has received 2 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. CLOV average Analyst price target in the last month is 4.650.
Based on analysts' estimates, CLOV EPS is projected to reach 0.000 in FY2026Q3, following reported EPS of 0.053 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.